SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-010860
Filing Date
2020-05-15
Accepted
2020-05-15 07:26:21
Documents
64
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bcda20200331_10q.htm 10-Q 559698
2 EXHIBIT 4.1 ex_186905.htm EX-4.1 35243
3 EXHIBIT 31.1 ex_181322.htm EX-31.1 14474
4 EXHIBIT 31.2 ex_181323.htm EX-31.2 15086
5 EXHIBIT 32.1 ex_181324.htm EX-32.1 5578
6 EXHIBIT 32.2 ex_181325.htm EX-32.2 5596
  Complete submission text file 0001437749-20-010860.txt   3252468

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT bcda-20200331.xml EX-101.INS 518856
8 XBRL TAXONOMY EXTENSION SCHEMA bcda-20200331.xsd EX-101.SCH 46302
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcda-20200331_cal.xml EX-101.CAL 30191
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20200331_def.xml EX-101.DEF 270800
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20200331_lab.xml EX-101.LAB 247286
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20200331_pre.xml EX-101.PRE 297057
Mailing Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070
Business Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38999 | Film No.: 20880585
SIC: 2836 Biological Products, (No Diagnostic Substances)